Safety and Performance of a GLOBAL Mapping and Ablation Device for the Treatment of Atrial Fibrillation (GLOBAL-AF)

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

October 31, 2017

Study Completion Date

August 31, 2019

Conditions
Atrial Fibrillation
Interventions
DEVICE

Global mapping and ablation device

During the procedure the Globe catheter will be delivered via standard femoral vein access and transseptal puncture. Anatomical and electrophysiological mapping of the LA will be followed by pulmonary vein isolation (PVI) by RF ablation. Additional lesions will be created as deemed appropriate by the investigator.

Trial Locations (2)

D-04289

Herzzentrum Leipzig GmbH, Leipzig

CH-8032

Klinik Hirslanden, Zurich

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Kardium Inc.

INDUSTRY